newsfilter
← Latest News
GlobeNewswire·

Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update

SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq: EIDX), a subsidiary of BridgeBio Pharma, Inc. (BridgeBio) (Nasdaq:BBIO), today reported its financial...